Provided by Tiger Fintech (Singapore) Pte. Ltd.

FibroGen

10.97
+0.42003.98%
Post-market: 10.970.00000.00%18:03 EDT
Volume:16.21K
Turnover:175.13K
Market Cap:44.36M
PE:-21.42
High:11.09
Open:10.78
Low:10.46
Close:10.55
52wk High:21.94
52wk Low:4.50
Shares:4.04M
Float Shares:3.62M
Volume Ratio:0.35
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5122
EPS(LYR):-11.8895
ROE:-1015.79%
ROA:-16.40%
PB:-0.20
PE(LYR):-0.92

Loading ...

FibroGen Inc: Upon Close of Sale of FibroGen China, Cash Runway Extended Into 2028

THOMSON REUTERS
·
Aug 12

FibroGen Inc - Sale of FibroGen China to AstraZeneca Expected to Be for $210 Mln

THOMSON REUTERS
·
Aug 12

FibroGen Inc expected to post a loss of $2.31 a share - Earnings Preview

Reuters
·
Aug 09

FibroGen Inc : H.c. Wainwright Adjusts Target Price to $43 From $10 to Reflect 1-for-25 Reverse Stock Split

THOMSON REUTERS
·
Aug 07

FibroGen Inc. Receives Positive FDA Feedback for Advancing Roxadustat in Phase 3 Trial for Anemia in Lower-Risk Myelodysplastic Syndromes

Reuters
·
Aug 07

FibroGen Announces Positive Type C Meeting With the FDA for Roxadustat in Patients With Anemia Associated With Lower-Risk Myelodysplastic Syndromes

THOMSON REUTERS
·
Aug 07

FibroGen Inc expected to post a loss of $2.31 a share - Earnings Preview

Reuters
·
Aug 01

Connect Biopharma Holdings Ltd. Appoints Industry Veteran Jim Schoeneck to Board of Directors, Expanding Leadership Team

Reuters
·
Jul 22

FibroGen Inc. Reduces Minimum Cash Balance Requirement in Revised Financing Agreement

Reuters
·
Jul 15

Director James A. Schoeneck Reports Acquisition of Common Shares in FibroGen Inc

Reuters
·
Jul 03

FibroGen Enters Relicensing Agreement with HiFiBiO

Dow Jones
·
Jun 14

BRIEF-Fibrogen Inc - On June 12 Enters Termination, Asset Transfer And License Agreement With Hifibio

Reuters
·
Jun 14

FibroGen Inc. Announces 1-for-25 Reverse Stock Split to Boost Share Price

Reuters
·
Jun 13

FibroGen Inc. Appoints Dr. Michael Kauffman to Board of Directors as Part of Strategic Leadership Shift

Reuters
·
Jun 10

FibroGen Inc. Files Initial Beneficial Ownership Statement for Director Michael Kauffman

Reuters
·
Jun 07

FibroGen Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
May 13

FibroGen Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

FibroGen Q1 EPS $0.05 Beats $0.02 Estimate, Sales $2.74M Beat $2.00M Estimate

Benzinga
·
May 13

FibroGen Inc. Reports Q1 2025 Revenue Drop to $2.7M, Net Loss Narrows to $16.8M, EPS at -$0.16

Reuters
·
May 13

FibroGen Inc expected to post earnings of 2 cents a share - Earnings Preview

Reuters
·
May 10